Stem cell therapy has shown great promise in treating a variety of diseases. However, many of the sites targeted for stem cell delivery are internal to the body and therefore difficult to access. Stem cell patches and injections have sought to overcome this obstacle, but this gives rise to the challenge of fixing the stem cells in place long enough to perform their therapeutic function before dispersing in the blood stream. Of particular interest to researchers is how to treat abdominal aortic aneurysms (AAA), which are the 15th leading cause of death in the United States. While traditional surgery fails to cover many patients in need of care and subjects others to unnecessary risks, the delivery of adipose-derived mesenchymal stem cells treatment has been shown in the lab to halt AAA progression. In order to adopt this therapeutic treatment to clinical studies, a minimally-invasive and robust means of localized delivery and cellular fixation is necessary.
